© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Glaxo Wellcome agreed to pay the University royalties on the worldwide sale of Ziagen, an AIDS-inhibiting drug, University President Mark Yudof announced Tuesday. About two-thirds of the royalty ...
The merger of Wellcome and Glaxo in 1995 left the Wellcome Trust with a 4.7% stake in the new company, Glaxo-Wellcome, and it now has an asset base of more than £12 billion. Research grant ...
To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...
At the time of the study, Fred Cox was Associate Director, Health Outcomes, US Medical Affairs, at Glaxo Wellcome Inc., Research Triangle Park, North Carolina. Zeba M. Khan is Senior Health ...
At first glance, there's not much difference between GlaxoSmithKline and AstraZeneca. Both are massive UK-listed drug companies. Both are popular with defensive investors. But when it comes to ...
GlaxoSmithKline is to team up with two UK ... is to work with the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute to create the new Centre for Therapeutic ...
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback